Schizophrenia & Psychosis at Psych Congress 2026
9 sessions on schizophrenia & psychosis · September 15–19, 2026, New Orleans, LA. Compare schizophrenia & psychosis at other meetings →
Tuesday, September 15
Symposium · MasterClass
MasterClass: Presynaptic Possibilities: The Past, Present, and Future of Modulating Dopamine
Christoph U. Correll · Chelsie Monroe
Covers presynaptic dopamine modulation in schizophrenia and bipolar I mania, including evidence for selective muscarinic agents and how to apply them to individual patients.
Symposium · Substance Use Disorders
Cannabis Use and Mental Illness: What We Now Know (and Don't)
Updates clinicians on cannabis-induced psychosis, mood effects, and dose-response data amid rising THC potency, with practical tapering strategies and treatment pathways for cannabis use disorder.
Wednesday, September 16
Symposium · Psychotic Disorders
Not All Delusions are Schizophrenia: Understanding Delusional Disorders and the Overlap with Substance Induced Psychosis
Uses a historic case to teach differential diagnosis of psychosis beyond schizophrenia — substance-induced, delusional, and medical causes — including temporal analysis, labs, and imaging.
Measurement-Based Care & Diagnosis · Substance Use Disorders
Symposium · Bipolar Disorders
Deprescribing Definitions and Decisions Differ by Diagnosis: A Deep Dive for Bipolar & Schizophrenia Disorders
Joseph Goldberg · Peter Weiden
Compares how polypharmacy patterns and risk-benefit calculations shape deprescribing decisions differently in bipolar disorder versus schizophrenia.
Symposium · Latest Discoveries & Emerging Trends
Latest Discoveries & Emerging Trends in Psychotic Disorders
Christoph U. Correll · Ilan Melnick
Fast-paced review of the year's most significant schizophrenia and psychosis research, with expert commentary and selected poster presenters sharing emerging data.
Thursday, September 17
Lecture · Difficult Medicines
Difficult Medicines: Navigating the Complexities of Clozapine
Deep dive into clozapine for treatment-resistant schizophrenia — initiation, monitoring requirements, side-effect management, and adherence — grounded in real-world cases.
Friday, September 18
Symposium · MasterClass
MasterClass: Operationalizing Adherence: A Practical Guide to LAI Integration in Schizophrenia Care
Megan Ehret · Jaden Todd · Emma Nelson · Ilan Melnick · Amber Hoberg · Kevin Williams
Compares available long-acting injectable antipsychotic formulations and offers patient-centered communication and logistics strategies for initiating, administering, and reintroducing LAIs.
Saturday, September 19
Symposium · AAGP Partner Session
Psychosis, Dementia, or Depression? Clarifying Cognitive Decline in Older Adults
Shilpa Srinivansan · Amber Hoberg
Structured differential-diagnosis approach for cognitive and behavioral change in older adults, incorporating blood-based biomarkers, neuroimaging, and longitudinal tracking while managing neuropsychiatric symptoms. Developed with the American Association for Geriatric Psychiatry.
Dementia & Cognitive Disorders · Geriatric · Measurement-Based Care & Diagnosis
Debate · Schizophrenia
When Standard Treatment Isn't Enough: Complex Schizophrenia Cases and Clinical Decision-Making
Leslie Citrome · Erin Crown · Brooke Kempf
Panel works through challenging schizophrenia cases involving treatment resistance and functional decline, covering sequencing, clozapine timing, augmentation, and metabolic and sedation trade-offs.
Antipsychotic Prescribing · Clozapine · GLP-1 & Metabolic Psychiatry
Other topics at this meeting
Depression 10Neuroscience & Mechanisms 10Measurement-Based Care & Diagnosis 8Drug Pipeline & Clinical Trials 7Sleep & Insomnia 7ADHD 6Bipolar Disorder 6Drug Interactions & Safety 6Lifestyle & Integrative Psychiatry 6Psychotherapy 6Antipsychotic Prescribing 5Anxiety Disorders 5